CRL Stock Analysis: Buy, Sell, or Hold?
CRL - Charles River Laboratories International, Inc.
$230.69
1.60 (0.70%)
▲
5d:
+8.45%
30d:
+31.98%
90d:
+31.9%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When CRL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: CRL is 9.5% above its trading range ($210.67). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: CRL is 9.5% above its trading range ($210.67). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$275.48
Based on 7.5% avg growth
INTRINSIC VALUE TODAY
$171.05
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CRL is currently trading at $230.69, which is considered extended relative to its 30-day fair value range of $172.79 to $210.67. From a valuation perspective, the stock is trading at a premium (Forward PE: 18.7) compared to its historical average (15.6). At these levels, the market is pricing in 6.3% annual earnings growth.
Technical Outlook: Technically, CRL is showing sideways momentum. The price is approaching resistance at $193.81. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CRL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CRL is showing sideways momentum. The price is approaching resistance at $193.81. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CRL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$172.79 -
$210.67
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
53.3%
All Signals
- BEARISH: Price extended above range (+9.5% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Trading above Wall St target ($215.33)
- BULLISH: Expecting earnings turnaround to 6.3% growth with 1.2% revenue growth
Trading Range Analysis
30-Day Trading Range
$172.79 -
$210.67
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$180.55
Resistance Level
$193.81
Current Trend
Sideways
Technical data as of
Jun 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.73
Wall Street Target
$215.33
(-6.7%)
Revenue Growth (YoY)
1.2%
Earnings Growth (YoY)
-17.3%
Profit Margin
-4.6%
Valuation Premium vs History
+6.3% premium
PE vs Historical
18.7 vs 15.6
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.3%
(market-implied from PE analysis)
1-Year Target
$245.22
(+6%)
2-Year Target
$260.67
(+13%)
3-Year Target
$277.09
(+20%)
3-Yr Target (if PE normalizes)
(PE: 19→16)
PE COMPRESSION
$230.79
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 11.0%)
$366.99
(+59%)
Base:
(SPY PE: 18.7, Growth: 11.0%)
$315.59
(+37%)
Bear:
(PE: 15.6, Growth: 11.0%)
$262.86
(+14%)
Share & Embed Analysis
Last updated: July 04, 2026 5:23 AM ET
Data refreshes hourly during market hours. Next update: 6:23 AM
Data refreshes hourly during market hours. Next update: 6:23 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRL showing a specific setup today?
Insider Activity (6 Months)
1
Buys
1
Sells
0
Net
NEUTRAL
Recent Transactions
Ro Khanna
BUY
2026-03-30
Ro Khanna
SELL
2026-02-05
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$599 | 64 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 64 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$144 | 61 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$260 | 54 HOLD |
